Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic. To read the full story.
Recent Posts
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
- CTSA Translational Impact Summit on March 2&3 (Virtual) – Register Now!
- Join NJ ACTS for Boosted: The Impact of Science, Society, and Policy on Public Health on 2/27 at 12
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS on 2/12 at 4pm for the Pilots Program 2026 Webinar
Categories
- Community (2,439)
- Covid (997)
- CTO Events (6)
- News (3,091)
- Pilots (21)